Hepatic allograft arterialization by means of the gastroduodenal bifurcation (branch patch) as a prognostic factor

Transplantation
J C Meneu-DiazA Moreno Elola-Olaso

Abstract

Because of the current shortage of cadaveric organs, it is important to determine preoperatively those variables that are readily available, inexpensive, and noninvasive that can predict a higher incidence of hepatic artery thrombosis (HAT). From April 1986 to October 2001, 717 patients underwent 804 liver transplants. All the arterial reconstructions were performed with fine (7-0) monofilament sutures in an interrupted fashion. Two methods were used: group I, end-to-end arterial anastomosis, and group II, the gastroduodenal branch patch. After a mean follow-up of 72 (range 3-174) months, HAT was observed in 19 patients (overall incidence 2.4%). End-to-end anastomosis (group I) was performed in 39.50% (316) of cases, and HAT developed in 14 (4.4%) cases. Branch-patch anastomoses (group II) were carried out in 60.5% (488) of the patients; the presence of HAT was detected in five cases (1.03%) (P = 0.03, P < 0.05). A total of 21 variables were selected in the univariate analysis; however, after the multivariate analysis, all but two of the factors lost statistical significance, and these corresponded to the type of arterial reconstruction (gastroduodenal branch patch vs. end-to-end) and the ABO compatibility. Liver transplantatio...Continue Reading

References

Jan 1, 1995·AJR. American Journal of Roentgenology·P LegmannA Bonnin
Dec 10, 1997·Transplantation·E HatanoY Yamaoka
Feb 15, 2001·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·S PastacaldiA K Burroughs
Mar 27, 2001·Transplantation Proceedings·B StangeP Neuhaus
Apr 18, 2001·Saudi Medical Journal·K A Abou EllaH M Rabea

❮ Previous
Next ❯

Citations

Nov 27, 2008·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Sascha A MüllerJan Schmidt
Aug 9, 2013·Paediatric Drugs·D ThangarajahA Dhawan
Nov 16, 2005·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Tomoko UmedaTohru Tani
Jan 23, 2008·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·J SchmidtM W Büchler
Jun 3, 2009·Clinical Transplantation·Wojciech G PolakMaarten J H Slooff
Mar 21, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·J BekkerK P de Jong
Nov 15, 2006·Clinical Transplantation·S A MullerJ Schmidt
Mar 1, 2007·Transplant International : Official Journal of the European Society for Organ Transplantation·Giuliano TestaEnrico Benedetti
May 29, 2020·Journal of Hepato-biliary-pancreatic Sciences·Jangho ParkSang-Jae Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.